Saffron inhibits the proliferation of hepatocellular carcinoma via inducing cell apoptosis.
Liver cancer remains the third leading cause of cancer-related mortality worldwide. The aim of this study was to explore the effect of saffron on liver cancer cell line QGY-7703 and the underlying molecular mechanism. Cell growth was detected by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay and cell cycle was assessed by flow cytometry. Besides, cell apoptosis was analyzed by Annexin V/PI (Propidium Iodide) staining, and the senescent cells morphology staining of β-galactosidase was evaluated by microscopy. In addition, ELISA (enzyme-linked immunosorbent assay) Kit was used to assess the activity of telomerase. Moreover, reverse transcription-PCR (polymerase chain reaction) and Western blot analysis was applied to detect mRNA and protein expression levels, respectively. Saffron treatment in QGY-7703 cells could significantly inhibit cell growth, arrest cell cycle in the G0/G1 phase, and induce cell apoptosis. Besides, the treatment of saffron could obviously decrease telomerase activity and hTERT level in QGY-7703 cells. In addition, enhanced Bax/Bcl-2 ratio and increased expression of P21 were found in saffron-treated cells. Moreover, we found that the number of senescent cells increased dramatically and the morphology of cells changed obviously after saffron treatment. Saffron administration may provide some experimental evidence for the inhibitory effect of saffron on the proliferation of QGY-7703 cells, suggesting that saffron may have potential utility for the treatment of liver cancer.